NextPlat's PharmcoRx Earns NABP Specialty Pharmacy Accreditation Strengthening its Credentials for New Opportunities with Healthcare Institutions and Providers
Rhea-AI Summary
NextPlat (NASDAQ:NXPL) announced that its PharmcoRx subsidiary has earned Specialty Pharmacy Accreditation from the National Association of Boards of Pharmacy (NABP). This voluntary accreditation recognizes advanced pharmacy services and disease management capabilities for medications requiring special handling, storage, and distribution.
According to NextPlat, PharmcoRx met comprehensive standards in patient management, quality management, and regulatory compliance. The company views this as a key milestone in its multi-year strategy to expand high-value pharmacy and specialty care services and strengthen relationships with large healthcare providers, payers, pharmaceutical manufacturers, and other institutional partners across the United States.
Positive
- PharmcoRx earns NABP Specialty Pharmacy Accreditation, validating advanced clinical and operational standards
- Independent accreditation expected to support relationships with large healthcare providers and payers
- Milestone in multi-year strategy to expand high-value pharmacy and specialty care services in the U.S.
Negative
- None.
News Market Reaction – NXPL
In the Jul 20 session, NXPL declined 1.20%, reflecting a mild negative market reaction. Argus tracked a peak move of +4.7% during that session. Our momentum scanner triggered 6 alerts that day, indicating moderate trading interest and price volatility.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Jul 15 | Pharmacy acquisition | Positive | -5.4% | Agreed to acquire a Florida pharmacy for cash and expand PharmcoRx's regional footprint. |
| May 14 | Quarterly earnings | Negative | -2.3% | Reported lower quarterly revenue despite improved gross margin and a narrowed net loss. |
| May 07 | Earnings scheduling | Neutral | -2.4% | Scheduled release of first-quarter 2026 financial results and management conference call. |
| Apr 29 | Margin guidance | Positive | -2.9% | Forecast higher gross margins, lower operating expenses, and positive operating income in Q3. |
| Apr 27 | Nasdaq compliance | Positive | +3.9% | Regained compliance with Nasdaq's minimum bid price requirement. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Recent company news showed four negative reactions among five events, with positive operational announcements generally diverging from the price response.
Key Terms
specialty pharmacy accreditation regulatory
AI-generated analysis. How Rhea-AI works. Not financial advice.
NABP's Specialty Pharmacy Accreditation signifies to patients, payers, and providers that the pharmacy organization is recognized for providing an advanced level of pharmacy services and disease management for patients taking medications that require special handling, storage and distribution requirements. Specialty pharmacies coordinate patient education, promote adherence and ensure appropriate medication use. This voluntary accreditation process required PharmcoRx to demonstrate compliance with a comprehensive set of practice standards and evaluated the pharmacy on patient management, quality management, and regulatory compliance. The Company believes that independent validation can enhance PharmcoRx's standing with large healthcare providers, payers, pharmaceutical manufacturers and other potential partners evaluating qualified specialty pharmacy organizations.
Birute Norkute, Vice President of Healthcare Operations at NextPlat, said, "Receipt of NABP Specialty Pharmacy accreditation is a significant milestone in the continued development of PharmcoRx and provides independent validation of the clinical, operational and compliance infrastructure we have been building. Through NABP accreditation and our continued focus on innovative approaches to technology services and patient care solutions we offer, our team is committed to serving the evolving needs of our growing network of institutional clients and building confidence in PharmcoRx as their preferred pharmacy services partner."
Accreditation by the National Association of Boards of Pharmacy® is part of PharmcoRx's multi-year effort to enhance the commercial potential of its healthcare operations. These ongoing efforts include expanding the variety and scope of high value pharmacy and specialty care services offered to retail customers while scaling its reach in support of multi-facility institutional healthcare providers operating across
For more information about NextPlat, please visit www.NextPlat.com and connect with us on Facebook, LinkedIn and X.
About NextPlat Corp
NextPlat is a global consumer products and services company providing healthcare and technology solutions through e-commerce and retail channels worldwide. Through acquisitions, joint ventures, and collaborations, the Company seeks to provide access to high quality, diversified healthcare and pharmacy services and assist businesses in selling their goods online, domestically, and internationally, allowing them to optimize their e-commerce presence and revenue. Through its subsidiaries, NextPlat provides pharmacy and healthcare data management services and prescription fulfilment services in
About the National Association of Boards of Pharmacy®
The National Association of Boards of Pharmacy® (NABP®) is the impartial professional organization that supports its member regulatory state boards of pharmacy in creating uniform regulations to protect public health. Founded in 1904, NABP aims to ensure the public's health and safety through its pharmacist competence assessment programs, license transfer and verification services, as well as through pharmacy inspection and accreditation programs.
Forward-Looking Statements
Certain statements in this release constitute forward-looking statements. These statements include the capabilities and success of the Company's business and any of its products, services or solutions. The words "believe," "forecast," "project," "intend," "expect," "plan," "should," "would," and similar expressions and all statements, which are not historical facts, are intended to identify forward-looking statements. These forward-looking statements involve and are subject to known and unknown risks, uncertainties and other factors, including the Company's ability to enhance the commercial potential of its healthcare operations and expand the variety and scope of the high value pharmacy and specialty care services offered as a result of accreditation by the National Association of Boards of Pharmacy and its ability to grow and expand as intended, any of which could cause the Company to not achieve some or all of its goals or the Company's previously reported actual results, performance (finance or operating), including those expressed or implied by such forward-looking statements. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company's filings with the Securities and Exchange Commission (the "SEC"), copies of which may be obtained from the SEC's website at www.sec.gov. The Company assumes no, and hereby disclaims any, obligation to update the forward-looking statements contained in this press release.
Media and Investor Contact for NextPlat Corp:
Michael Glickman
MWGCO, Inc.
917-397-2272
mike@mwgco.net
View original content to download multimedia:https://www.prnewswire.com/news-releases/nextplats-pharmcorx-earns-nabp-specialty-pharmacy-accreditation-strengthening-its-credentials-for-new-opportunities-with-healthcare-institutions-and-providers-302829163.html
SOURCE NextPlat Corp.